Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for treatment of venous thromboembolism in cancer patients (phase III)
2015-001478-16Phase 3Suspended
- Sponsor
- AIO-Studien
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rivaroxaban in venous thromboembolism (VTE) (2 arms), sponsored by AIO-Studien. Primary endpoint: Patient treatment satisfaction (convenience). Started Sep 2015; status: suspended.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2015-001478-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001478-16.